The effect of PDE5 inhibitors on bone and oxidative damage in ovariectomy-induced osteoporosis

Alp H. H., Huyut Z., YILDIRIM S., Başbuğan Y., Ediz L., Sekeroglu M. R.

EXPERIMENTAL BIOLOGY AND MEDICINE, vol.242, no.10, pp.1051-1061, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 242 Issue: 10
  • Publication Date: 2017
  • Doi Number: 10.1177/1535370217703352
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1051-1061
  • Keywords: Bone loss, tadalafil, udenafil, vardenfil, nitric oxide signalling pathway, asymmetric dimethylarginine, bone mass density, oxidative stress, NITRIC-OXIDE, PHOSPHODIESTERASE-5 INHIBITORS, SILDENAFIL CITRATE, MINERAL DENSITY, NADPH OXIDASE, CYCLIC-GMP, SHORT-TERM, STRESS, RAT, THERAPY
  • Van Yüzüncü Yıl University Affiliated: Yes


Osteoporosis is a major public health problem associated with many factors, and it affects more than 50% of women over 50 years old. In the current study, our purpose was to investigate the effects of phosphodiestarase-5 inhibitors on osteoporosis via the nitric oxide/3',5'-cyclic guanosine monophosphate/protein kinase G signalling pathway. A total of 50 female albino Wistar rats were separated into five groups. The first group was appointed as the healthy control group with no ovariectomy. All animals in the other groups underwent a bilateral ovariectomy. Six months after the ovariectomy, vardenafil, udenafil and tadalafil were given to the third, fourth and fifth groups, respectively, but were not administered to the positive control group (10 mg/kg per day for two months). The bone mineral density values were determined using a densitometry apparatus for all groups pre- and post-ovariectomy as well as after treatment. The levels of nitric oxide, endothelial nitric oxidesynthase, asymmetric dimethylarginine, 3',5'-cyclic guanosine monophosphate, protein kinase G, phosphodiestarase-5, pyridinoline, deoxypyridinoline, carboxyterminal telopeptide fragments and plasma carboxy terminal propeptide of type I collagen were determined using an enzyme linked immunosorbent assay. The levels of malondialdehyde, 8-hydroxy-2-deoxy guanosine, deoxyguanosine and coenzyme Q10 were determined by a high-performance liquid chromatography assay. Additionally, the right femoral trabecular bone density and the epiphyseal plate were measured in all groups. Angiogenesis was histologically observed in the bone tissue. In addition, we determined that the inhibitors may have caused a positive impact on the increased bone mass density and reduction of bone resorption markers. We also observed the positive effects of these inhibitors on oxidative stress. In conclusion, these phosphodiestarase-5 inhibitors increase angiogenesis in bone tissue and improve the re-formation rate of bone in rats with osteoporosis.